Last update 01 Nov 2024
Beijing Orient Yunjia Technology Development Co., Ltd.
Last update 01 Nov 2024
Overview
Tags
Respiratory Diseases
Infectious Diseases
Immune System Diseases
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
苏黄止咳颗粒治疗儿童感冒后咳嗽（风邪犯肺、肺气失宣证）有效性和安全性的随机、双盲、安慰剂平行对照、多中心II期临床研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II clinical study on the efficacy and safety of Suhuang cough granules in the treatment of post-cold cough in children (wind evil invading the lungs, lung qi failure syndrome)
苏黄止咳颗粒治疗成人咳嗽变异性哮喘（风邪犯肺、肺气失宣证）有效性和安全性的随机、双盲、原剂型对照、多中心Ⅱ期临床研究
[Translation] A randomized, double-blind, original dosage form controlled, multicenter phase II clinical study on the efficacy and safety of Suhuang cough granules in the treatment of cough variant asthma in adults (wind evil invading the lungs, lung qi failure syndrome)
苏黄止咳颗粒治疗成人感冒后咳嗽（风邪犯肺、肺气失宣证）有效性和安全性的随机、双盲、原剂型对照、多中心II期临床研究
[Translation] A randomized, double-blind, original dosage form controlled, multicenter phase II clinical study on the efficacy and safety of Suhuang cough granules in treating cough after cold in adults (wind evil invading the lungs, lung qi failure syndrome)
100 Clinical Results associated with Beijing Orient Yunjia Technology Development Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Beijing Orient Yunjia Technology Development Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Orient Yunjia Technology Development Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 25 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
1
NDA/BLA
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free